These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22037092)

  • 1. Clinical psychopharmacology of borderline personality disorder: an update on the available evidence in light of the Diagnostic and Statistical Manual of Mental Disorders - 5.
    Ripoll LH
    Curr Opin Psychiatry; 2012 Jan; 25(1):52-8. PubMed ID: 22037092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychopharmacologic treatment of borderline personality disorder.
    Ripoll LH
    Dialogues Clin Neurosci; 2013 Jun; 15(2):213-24. PubMed ID: 24174895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotics, antidepressants, anticonvulsants, and placebo on the symptom dimensions of borderline personality disorder: a meta-analysis of randomized controlled and open-label trials.
    Vita A; De Peri L; Sacchetti E
    J Clin Psychopharmacol; 2011 Oct; 31(5):613-24. PubMed ID: 21869691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological interventions for borderline personality disorder.
    Stoffers J; Völlm BA; Rücker G; Timmer A; Huband N; Lieb K
    Cochrane Database Syst Rev; 2010 Jun; (6):CD005653. PubMed ID: 20556762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms.
    Mercer D; Douglass AB; Links PS
    J Pers Disord; 2009 Apr; 23(2):156-74. PubMed ID: 19379093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and emerging medications for borderline personality disorder: is pharmacotherapy alone enough?
    Bozzatello P; Rocca P; De Rosa ML; Bellino S
    Expert Opin Pharmacother; 2020 Jan; 21(1):47-61. PubMed ID: 31693423
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential effectiveness of antipsychotics in borderline personality disorder: meta-analyses of placebo-controlled, randomized clinical trials on symptomatic outcome domains.
    Ingenhoven TJ; Duivenvoorden HJ
    J Clin Psychopharmacol; 2011 Aug; 31(4):489-96. PubMed ID: 21694626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological treatment for patients with borderline personality disorder: practice and study results].
    Schwerthöffer D; Bäuml J; Rentrop M
    Fortschr Neurol Psychiatr; 2013 Aug; 81(8):437-43. PubMed ID: 23939557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of borderline personality disorder to the affective disorders.
    Kroll J; Ogata S
    Psychiatr Dev; 1987; 5(2):105-28. PubMed ID: 2888107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacotherapy effectiveness for some symptoms of borderline personality disorder].
    Benjaminsen S
    Ugeskr Laeger; 2014 Sep; 176(36):. PubMed ID: 25293847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing an individualized treatment plan for patients with schizoaffective disorder: from pharmacotherapy to psychoeducation.
    Vieta E
    J Clin Psychiatry; 2010; 71 Suppl 2():14-9. PubMed ID: 21190648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary study of the naturalistic course of non-manualized psychotherapy for outpatients with borderline personality disorder: Patient characteristics, attrition and outcome.
    Nysaeter TE; Nordahl HM; Havik OE
    Nord J Psychiatry; 2010 Apr; 64(2):87-93. PubMed ID: 19958254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy for borderline personality disorder--current evidence and recent trends.
    Stoffers JM; Lieb K
    Curr Psychiatry Rep; 2015 Jan; 17(1):534. PubMed ID: 25413640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of borderline personality disorder symptoms in a nonclinical sample.
    Taylor J; Reeves M
    J Clin Psychol; 2007 Sep; 63(9):805-16. PubMed ID: 17674400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marginalization of borderline personality disorder.
    Kealy D; Ogrodniczuk JS
    J Psychiatr Pract; 2010 May; 16(3):145-54. PubMed ID: 20485102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials of treatment for personality disorders.
    Paris J
    Psychiatr Clin North Am; 2008 Sep; 31(3):517-26, viii. PubMed ID: 18638650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder.
    Tadić A; Wagner S; Hoch J; Başkaya O; von Cube R; Skaletz C; Lieb K; Dahmen N
    Psychopathology; 2009; 42(4):257-63. PubMed ID: 19521142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Borderline case].
    Harada S
    Ryoikibetsu Shokogun Shirizu; 2003; (38):71-5. PubMed ID: 12876933
    [No Abstract]   [Full Text] [Related]  

  • 20. A developmental, mentalization-based approach to the understanding and treatment of borderline personality disorder.
    Fonagy P; Luyten P
    Dev Psychopathol; 2009; 21(4):1355-81. PubMed ID: 19825272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.